US Patent 7238341 Peptide-based multimeric targeted contrast agents
Patent 7238341 was granted and assigned to EPIX Pharmaceuticals, Inc. on July, 2007 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7238341 Peptide-based multimeric targeted contrast agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
